The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
Wenchao Xie,1 Ying Luo,2 Xiangwen Liang,1 Zhihai Lin,1 Zhengdong Wang,1 Ming Liu1 1Department of Cardiology, Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi 537000, People’s Republic of China; 2Graduate School, Guangxi Medical University, Nanning, Guangxi 530021, Pe...
Saved in:
Main Authors: | Xie W (Author), Luo Y (Author), Liang X (Author), Lin Z (Author), Wang Z (Author), Liu M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The benefit and safety of aspirin for primary prevention of ischemic stroke: a meta-analysis of randomized trials
by: Hong Lei, et al.
Published: (2016) -
US population qualifying for aspirin use for primary prevention of cardiovascular disease
by: Athena L. Huang, et al.
Published: (2024) -
US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
by: Athena L. Huang, MD, et al.
Published: (2023) -
Which people should take aspirin for primary prevention of cardiovascular disease?
by: Lozano R, et al.
Published: (2015) -
The Efficacy and Safety of Topiramate in the Prevention of Pediatric Migraine: An Update Meta-Analysis
by: Xinwei Wu, et al.
Published: (2020)